top border
top border
Featured Programs

Dr. Finn on Regorafenib for the Treatment of Patients With HCC
Richard Finn, assistant professor of Medicine at the Geffen School of Medicine, Department of Medicine, Division of Hematology/Oncology at UCLA Jonsson Comprehensive Cancer Center, discusses regorafenib (Stivarga) for the treatment of patients with hepatocelluar carcinoma (HCC). View Now

Led by Johanna Bendell, MD, panelists Thomas A. Abrams, MD; George P. Kim, MD; Caio Max Rocha Lima, MD; and Philip A. Philip, MD, PhD, focus on emerging evidence in pancreatic cancer and how it is likely to impact patient care. View Now

 

Featured Video

Hepatocellular Carcinoma (HCC):
Can We Improve Patient Survival?

Hepatocellular Carcinoma (HCC): Can We Improve Patient Survival?
Richard Finn, MD, Laura M. Kulik, MD, and Matthew S. Johnson, MD, FSIR, discuss the evolving systemic treatment paradigm for patients with advanced hepatocellular carcinoma. View now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication
x